References

Age UK. More harm than good. Why more isn't always better with older people's medicines. 2019. https://tinyurl.com/t4ktyxav (accessed 9 April 2021)

Alder S, Caslake R, Mangoni A. Practical advice for prescribing in older people. Med Older People. 2017; 45:(1)11-14 https://doi.org/10.1016/j.mpmed.2016.10.004

Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013; 381:(9868)752-762 https://doi.org/10.1016/S0140-6736(12)62167-9

Dumbreck S, Flynn A, Nairn M Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015; 350 https://doi.org/10.1136/bmj.h949

Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008; 46:(2)72-83 https://doi.org/10.5414/cpp46072

Joint Formulary Committee. British National Formulary. 2021. https://tinyurl.com/wsywf53s (accessed 5 May 2021)

Lavan AH, Gallagher P, Parsons C, O'Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017; 46:(4)600-607 https://doi.org/10.1093/ageing/afx005

Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004; 57:(1)6-14 https://doi.org/10.1046/j.1365-2125.2003.02007.x

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017; 17:(1) https://doi.org/10.1186/s12877-017-0621-2

National Institute for Health and Care Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NG5. 2015. https://www.nice.org.uk/guidance/ng5 (accessed 6 May 2021)

National Institute for Health and Care Excellence. Multimorbidity: clinical assessment and management. NG56. 2016. https://tinyurl.com/48vp2duk (accessed 5 May 2021)

Navaratnarajah A, Jackson S. The physiology of ageing. Med Older Adults. 2016; 45:(1)6-10 https://doi.org/10.1016/j.mpmed.2016.10.008

NHS Digital. Prescription cost analysis: prescriptions dispensed in the community, 2016. 2017. https://tinyurl.com/tfzh4rxv (accessed 5 May 2021)

NHS England. Shared decision making summary guide. 2019. https://tinyurl.com/4pdwburd (accessed 7 May 2021)

Pirmohamed M, James S, Meaken S Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004; 329:(7456)15-19 https://doi.org/10.1136/bmj.329.7456.15

Pharmacokinetics in older adults. https://tinyurl.com/yz3cd6vf (accessed 4 May 2021)

Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing. 2018. https://tinyurl.com/yna2hf42 (accessed 21 May 2021)

Pharmacology, polypharmacy and the older adult: a review

02 June 2021
Volume 26 · Issue 6

Abstract

District nurses routinely visit and care for older patients who are prescribed multiple medicines. Older people living with multiple comorbidities and polypharmacy are commonly encountered in community nursing. It is important for nurses to recognise that regular medicines use and age-related physiological changes in older people place them at greater risk of medication-related harm. In order to understand this, an underpinning knowledge of the pharmacological principles relating to older people is required. This review will consider the effects of age-related changes and the impact of ageing on pharmacokinetics and pharmacodynamics. The relationship between polypharmacy and identifying high-risk drugs and adverse drug events will be explored. Medicines use in older adults with multimorbidity including frailty will be discussed. The role of district nurses in supporting older people with medicines optimisation will be considered, with a focus on how the community nurse can contribute to reducing avoidable harm for patients.

Prescribing a medicine is the most common clinical intervention in the NHS (National Institute for Health and Care Excellence (NICE), 2015). The trend in prescribing continues to grow year on year and the number of prescription items dispensed increased from 2006 to 2016 by 47% (NHS Digital, 2016). Prescribing in older people is very common, and it is estimated that, in England, more than 1 in 10 people aged over 65 years take at least eight different prescribed medications each week. This increases to nearly one-in-four among those aged over 85 years (Age UK, 2019).

Ageing brings about a number of changes in the body, and the ageing process begins to affect the way the body handles medicines around the time a person reaches their forties.

A combination of pharmacokinetic, pharmacodynamic and homeostatic changes slowly develops and becomes clinically significant as the person gets older. There is considerable variation in the onset rate and extent of significance. Biological age is a more important indicator than chronological age when trying to identify an older person who is at risk of an adverse reaction to prescribed medications.

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month